These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36699667)

  • 1. Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer.
    Christensen TD; Maag E; Larsen O; Feltoft CL; Nielsen KR; Jensen LH; Leerhøy B; Hansen CP; Chen IM; Nielsen DL; Johansen JS
    JHEP Rep; 2023 Mar; 5(3):100648. PubMed ID: 36699667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer.
    Christensen TD; Madsen K; Maag E; Larsen O; Jensen LH; Hansen CP; Markussen A; Høgdall DTS; Chen IM; Nielsen D; Johansen JS
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of carbohydrate antigen 50 in biliary tract cancer: A large-scale multicenter study.
    Wang YS; Wang W; Zhang SY; Cai W; Song RP; Mei T; Wang W; Zhang F; Qi FY; Zhang S; Liu Y; Li HR; Ji P; Gao M; Song HC; Yao HZ; Meng FZ; Lu Z; Wang JZ; Liu LX
    Cancer Med; 2024 Jun; 13(12):e7388. PubMed ID: 38924330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
    Shoda J; Matsuda A; Shida T; Yamamoto M; Nagino M; Tsuyuguchi T; Yasaka T; Tazuma S; Uchiyama K; Unno M; Ohkohchi N; Nakanuma Y; Kuno A; Narimatsu H
    J Gastroenterol; 2017 Feb; 52(2):218-228. PubMed ID: 27358229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The present roles and future perspectives of Interleukin-6 in biliary tract cancer.
    Zhou M; Na R; Lai S; Guo Y; Shi J; Nie J; Zhang S; Wang Y; Zheng T
    Cytokine; 2023 Sep; 169():156271. PubMed ID: 37331095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures.
    Sandanayake NS; Sinclair J; Andreola F; Chapman MH; Xue A; Webster GJ; Clarkson A; Gill A; Norton ID; Smith RC; Timms JF; Pereira SP
    Br J Cancer; 2011 Oct; 105(9):1370-8. PubMed ID: 21970875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer.
    Loosen SH; Breuer A; Tacke F; Kather JN; Gorgulho J; Alizai PH; Bednarsch J; Roeth AA; Lurje G; Schmitz SM; Brozat JF; Paffenholz P; Vucur M; Ritz T; Koch A; Trautwein C; Ulmer TF; Roderburg C; Longerich T; Neumann UP; Luedde T
    JHEP Rep; 2020 Apr; 2(2):100080. PubMed ID: 32140677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer.
    Høgdall D; O'Rourke CJ; Larsen FO; Zarforoushan S; Christensen TD; Ghazal A; Boisen MK; Muñoz-Garrido P; Johansen JS; Andersen JB
    J Hepatol; 2022 Oct; 77(4):1047-1058. PubMed ID: 35750139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.
    Leelawat K; Sakchinabut S; Narong S; Wannaprasert J
    BMC Gastroenterol; 2009 Apr; 9():30. PubMed ID: 19405942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer.
    Christensen TD; Jensen C; Larsen O; Leerhøy B; Hansen CP; Madsen K; Høgdall D; Karsdal MA; Chen IM; Nielsen D; Johansen JS; Willumsen N
    Int J Cancer; 2023 Mar; 152(5):1036-1049. PubMed ID: 36455598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential serum peptide biomarkers of biliary tract cancer using MALDI MS profiling.
    Sandanayake NS; Camuzeaux S; Sinclair J; Blyuss O; Andreola F; Chapman MH; Webster GJ; Smith RC; Timms JF; Pereira SP
    BMC Clin Pathol; 2014 Feb; 14(1):7. PubMed ID: 24495412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Novel Biomarker for Biliary Tract Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.
    Kikkawa S; Sogawa K; Satoh M; Umemura H; Kodera Y; Matsushita K; Tomonaga T; Miyazaki M; Yokosuka O; Nomura F
    Int J Proteomics; 2012; 2012():108609. PubMed ID: 22888427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma miR-21 is a novel diagnostic biomarker for biliary tract cancer.
    Kishimoto T; Eguchi H; Nagano H; Kobayashi S; Akita H; Hama N; Wada H; Kawamoto K; Tomokuni A; Tomimaru Y; Umeshita K; Doki Y; Mori M
    Cancer Sci; 2013 Dec; 104(12):1626-31. PubMed ID: 24118467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-glycan signatures identified in the serum from biliary tract cancer patients: Association with clinical diagnosis and prognosis.
    Huang C; Qiu Z; Wang M; Ji J; Xiao X; Wang Y; Xu X; Gao Z; Gao C
    J Hepatobiliary Pancreat Sci; 2024 Aug; 31(8):537-548. PubMed ID: 38824438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a serum biomarker panel for the differential diagnosis of cholangiocarcinoma and primary sclerosing cholangitis.
    Cuenco J; Wehnert N; Blyuss O; Kazarian A; Whitwell HJ; Menon U; Dawnay A; Manns MP; Pereira SP; Timms JF
    Oncotarget; 2018 Apr; 9(25):17430-17442. PubMed ID: 29707118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Therapies for Perihilar Cholangiocarcinoma.
    Gray S; Lamarca A; Edeline J; Klümpen HJ; Hubner RA; McNamara MG; Valle JW
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum NGAL to Clinically Distinguish Cholangiocarcinoma from Benign Biliary Tract Diseases.
    Leelawat K; Narong S; Wannaprasert J; Leelawat S
    Int J Hepatol; 2011; 2011():873548. PubMed ID: 21994874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Levels of CXCL13 Are an Independent Predictor of Survival Following Resection of Biliary Tract Cancer.
    Loosen SH; Ulmer TF; Labuhn S; Bednarsch J; Lang SA; Alizai PH; Schneider AT; Vucur M; Neumann UP; Luedde T; Roderburg C
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Expression of Plasma Thrombospondin-2 and CA19-9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach.
    Le Large TYS; Meijer LL; Paleckyte R; Boyd LNC; Kok B; Wurdinger T; Schelfhorst T; Piersma SR; Pham TV; van Grieken NCT; Zonderhuis BM; Daams F; van Laarhoven HWM; Bijlsma MF; Jimenez CR; Giovannetti E; Kazemier G
    Oncologist; 2020 Apr; 25(4):e634-e643. PubMed ID: 31943574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.